Mobimo Holding AG (MOBN.SW) stock: key figures, P/E, revenue and dividend
Real Estate · Switzerland · ISIN CH0011108872
Mobimo Holding AG financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 247.00 m CHF | 353.00 m CHF |
| Gross profit | 163.00 m CHF | 186.00 m CHF |
| Operating income | 132.00 m CHF | 152.94 m CHF |
| EBIT | 156.00 m CHF | 176.00 m CHF |
| Net income | 125.00 m CHF | 192.00 m CHF |
| Diluted EPS – continuing operations | 17.26 CHF | 25.99 CHF |
Full history since 2003, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Mobimo Holding AG
Mobimo Holding AG, together with its subsidiaries, operates as a real estate company in Switzerland. It operates in two segments, Real Estate and Development. The Real Estate segment engages in the portfolio management; purchase and sale of investment properties; initial letting and reletting of investment properties; sale of condominium; and property management, such as tasks and services of site management, property management, and facility management. The Development segment is involved in the development of investment properties, construction projects for third-party investors, and condominiums; acquisition of sites and building plots for development activities; construction projects; monitoring construction activity; and management of quality assurance process during the construction phase. The company was founded in 1999 and is headquartered in Lucerne, Switzerland.
More stocks
- DigitalBridge Group, Inc. (DBRG)
- Versigent PLC (VGNT)
- Hugo Boss (BOSS.DE)
- AMERICAN EAGLE OUTFITTERS INC (AEO)
- Dhc Software Co Ltd (002065.SZ)
- NEWMARK GROUP, INC. (NMRK)
- Shandong Weigao Blood (603014.SS)
- CES Energy Solutions Corp (CEU.TO)
- Sugi Holdings Co Ltd (7649.T)
- Beijing Capital Co Ltd (600008.SS)
- Jilin Aodong Pharmaceutical Group Co Ltd (000623.SZ)
- Denali Therapeutics Inc. (DNLI)
Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.